What the label lists and what reports show
Flurandrenolide side effects
Flurandrenolide's FDA label lists its adverse reactions in its own words. FAERS holds 329 reports naming it through July 30, 2026; the reaction reported most often, leaving out the conditions it is used for, product-use terms and outcomes, is pruritus (31 reports).
- Generic listed
Check it at the source: the flurandrenolide FDA label on DailyMed (effective October 11, 2022, Padagis Israel Pharmaceuticals Ltd); the FDA FAERS public dashboard.
What does the label list?
From the label: adverse reactionsThe following local adverse reactions are reported infrequently with topical corticosteroids but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: Burning Itching Irritation Dryness Folliculitis Hypertrichosis Acneiform eruptions Hypopigmentation Perioral dermatitis Allergic contact dermatitis The following may occur more frequently with occlusive dressings: Maceration of the skin Secondary infection Skin atrophy Striae Miliaria Postmarketing Adverse Reactions The following adverse reactions have been identified during post approval use of flurandrenolide lotion. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. …
Source: FDA drug label, Padagis Israel Pharmaceuticals Ltd, effective October 11, 2022 (SPL set 9c4f5aea-2e08-400c-88f6-d9e3013afda7), via openFDA; the full label on DailyMed
What do FAERS reports show?
329 reports list flurandrenolide among the medicines taken, each a report of something that happened, not proof the medicine caused it; 6 are coded as a death and 40 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is. Of the 22 reactions below, none is named by the same term (in US spelling) in the label's adverse reactions, warnings or patient leaflet; a reaction the label does not name may still be there under another word, and a report does not show that the medicine caused it.
The 25 most reported reactions
Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026; reactions as MedDRA preferred terms
What next?
- Flurandrenolide: the full record
- label, generics, price, shortages, recalls
- Report a side effect to the FDA
- MedWatch
- Side effects hub
- the most reported medicines and reactions